ENTITY

Karuna Therapeutics Inc (KRTX US)

7
Analysis
Health CareUnited States
Karuna Therapeutics, Inc. operates as a biotechnology company. The Company develops therapies for the treatment of chronic mental health disorder. Karuna Therapeutics serves patients in the United States.
more
07 Mar 2024 13:58

Karuna Therapeutics Inc (KRTX.US) - This Company Is Worth Bristol Myers Squibb Paying a High Premium

From clinical demand perspective, schizophrenia market is a field worth betting on by pharmaceutical companies.As FIC, KarXT will be the first...

Logo
312 Views
Share
08 Mar 2024 22:58

Karuna Therapeutics: Is The Bidding Battle Underway?

I see a strong wave of M&A activity in neuropsychiatry space and think the risk/reward of owning KRTX shares is favorable despite the substantial...

Logo
398 Views
Share
07 Mar 2024 18:37

Karuna Therapeutics (KRTX US): BMS Acquisition Offers Decent Short-Term Trading Opportunity

​BMS is acquiring Karuna Therapeutics for $330/share in cash, with the deal expected to close in 1H24. Current market price of Karuna shares...

Logo
289 Views
Share
bearishPureTech Health
10 Oct 2022 18:28

PureTech Health (PRTC LN): Possible Combination with Nektar Is Just a Defensive Move

Puretech shares gained ~20% since my bullish insight on the company on May 31. Investors should book profit amid uncertainty regarding possibility...

Logo
217 Views
Share
bullishPureTech Health
07 Sep 2022 19:37

PureTech Health (PRTC LN): Continued Value Unlocking; Multiple Catalysts Are Pushing Up Stock Price

PureTech raised $115.4 million through partial offloading of stake in Karuna Therapeutics, which has extended its operational runway into Q1 2026....

Logo
274 Views
Share
x